Trans-Omics for Precision Medicine (TOPMed)

Trans-Omics for Precision Medicine (TOPMed) aims to integrate whole-genome sequencing and data from other “omics” (such as epigenomics or protein expression) into larger studies with rich stores of molecular, behavioural, imaging, environmental, and clinical data. This initiative of the National Heart, Lung, and Blood Institute at the U.S. National Institutes of Health focuses on heart, lung, blood, and sleep disorders.